Upgrading Clinical Analysis Systems
Dermavant Sciences is a growing mid-market specialty biopharma company developing innovative medicines for dermatologic diseases. They were experiencing difficulties with the manual management of their Statistical Computing Environment (SCE) and data exchange, which raised concerns about the integrity of clinical analysis results. Additionally, their current SCE and processes were not scalable.
Read about how they were able to overcome these obstacles, leading to:
• A centralized and compliant system to minimize the compliance risk of delivering incorrect clinical trial results
• System implementation and ongoing maintenance burden removed from internal IT teams
• Ability to continue to execute their current processes with little to no impact on the end users
• No disruption to their clinical analysis workflows
